Skip to main content

Table 1 Imaging/biodistribution data collection schedule

From: Feasibility and advantage of adding 131I-MIBG to 90Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors

  Day 0 Day 1 Day 2
Radiopharmaceutical injection (131I-MIBG and 111In-pentetreotide) X   
Blood samples X (1 and 4 h) X X
Whole-body conjugate views X X X
SPECT X X X